The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan ...

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with ...

An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors.

The new kits offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes, for use in either flow cytometry or fluorescent western blot experiments.

If the antibody interacts with a key part of a microbial structure, it can block infection. Antibodies (like their targets) come in a dizzying array — which means that some antibodies block their ...

Here we investigate the N162 glycan’s role in FcγRIIIa structure, antibody-binding affinity and NK cell ADCC. We performed a mutational screen to identify FcγRIIIa residues that mediate antibody ...

An open label, phase 1b/2 trial of LVGN6051 (4-1BB agonistic antibody) combined with anlotinib for refractory soft tissue sarcoma (STS).. If you have the appropriate software installed, you can ...

In a paper recently published on hLife, Chinese scientists elucidate the 3.04 Å cryo-EM structure of HSV-1 gB bound to the neutralizing antibody D48. Through structural and sequence ...

Researchers have analyzed the antibody Immunoglobulin M in rainbow trout to shed some light on why these proteins may have evolved over time.